2 Growth Stocks That Could Deliver 1,000% Returns

Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders have been enjoying historic returns on capital over the past decade. For example, the central nervous system disorder drug specialist Axsome Therapeutics, the cancer specialist Exelixis, and the electric car pioneer Tesla have all delivered tenfold returns for investors who bought these names at their low points. 

Which stocks might be the next Axsome, Exelixis, or Tesla from a growth standpoint? The cancer/rare disease specialist Mereo BioPharma Group (NASDAQ: MREO) and the diabetes-focused medical device company Senseonics Holdings (NYSEMKT: SENS) could both be gearing up for a monstrous run higher soon. In fact, these two low-priced healthcare stocks have a decent shot at generating 1,000%-plus returns for their shareholders within the next two to three years.

Here's a brief overview on the risks and potential rewards associated with each of these promising growth vehicles.  

Continue reading

Source Fool.com